These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Severe community-acquired pneumonia: an Australian perspective. Wilson PA; Ferguson J Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544 [TBL] [Abstract][Full Text] [Related]
14. [Antibiotic therapy for community acquired Streptococcus pneumoniae pneumonia: clinical relevance of antibiotic resistance]. Bédos JP; Bruneel F Med Mal Infect; 2006; 36(11-12):667-79. PubMed ID: 16842956 [TBL] [Abstract][Full Text] [Related]
15. [What is new in the treatment of community-acquired pneumonia?]. Welte T; Marre R; Suttorp N; Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488 [TBL] [Abstract][Full Text] [Related]
16. C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ. Krüger S; Ewig S; Kunde J; Hanschmann A; Marre R; Suttorp N; Welte T; J Antimicrob Chemother; 2009 Jul; 64(1):159-62. PubMed ID: 19403654 [TBL] [Abstract][Full Text] [Related]
17. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532 [TBL] [Abstract][Full Text] [Related]
19. Community-acquired pneumonia: what is relevant and what is not? Talwar A; Lee H; Fein A Curr Opin Pulm Med; 2007 May; 13(3):177-85. PubMed ID: 17414124 [TBL] [Abstract][Full Text] [Related]
20. Moxifloxacin versus standard therapy in patients with pneumonia hospitalized after failure of preclinical anti-infective treatment. Wenisch C; Krause R; Széll M; Laferl H Infection; 2006 Aug; 34(4):190-5. PubMed ID: 16896576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]